Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
9 studies found for:    Open Studies | "Mucocutaneous Lymph Node Syndrome"
Show Display Options
Rank Status Study
1 Recruiting Etanercept in Kawasaki Disease
Conditions: Mucocutaneous Lymph Node Syndrome;   Kawasaki Disease
Interventions: Drug: Etanercept;   Drug: Placebo
2 Recruiting Epidemiologic Features of Kawasaki Disease in Shanghai From 2008 Through 2012
Condition: Kawasaki Disease
Intervention:
3 Recruiting Infliximab for Kawasaki Disease Patients Resistant to IVIG : a Multicentre, Prospective, Randomised Trial
Condition: Kawasaki Disease
Interventions: Drug: Infliximab;   Drug: IVIG
4 Unknown  Prevalence and Early Markers of Atherosclerosis in Adults With a History of Kawasaki Disease
Condition: Kawasaki Disease
Intervention: Other: Cardiac evaluation
5 Recruiting Anakinra in Infants and Children With Coronary Artery Abnormalities in Acute Kawasaki Disease
Condition: Kawasaki Disease
Intervention: Drug: Anakinra
6 Recruiting Trial of Atorvastatin on the Persistent Coronary Aneurysm in Children With Kawasaki Disease
Conditions: Kawasaki Disease;   Aneurysm, Coronary
Intervention: Drug: Atorvastatin
7 Recruiting Pharmacokinetics (PK)/Safety Study of Atorvastatin in Children With Kawasaki Disease and Coronary Artery Abnormalities
Condition: Kawasaki Disease
Intervention: Drug: Atorvastatin
8 Recruiting Etiology Study of Kawasaki Disease
Condition: Kawasaki Disease
Intervention:
9 Not yet recruiting Doxycycline Treatment to Prevent Progressive Coronary Artery Dilation in Children With Kawasaki Disease
Conditions: Kawasaki Disease;   Coronary Aneurysm
Interventions: Drug: Doxycycline;   Drug: Standard care

Indicates status has not been verified in more than two years